Methotrexate plus sulfasalazine is recommended in patients with all disease durations provided they have high disease activity and poor prognostic features.
甲氨喋呤加柳氮磺吡啶疗法是推荐给那些患病时间长久，病情高度活动、但是没有不良预后特征的患者。
Hydroxychloroquine plus sulfasalazine is recommended only for patients with intermediate disease duration (6-24 months) and high disease activity but without poor prognostic features.
羟氯喹加柳氮磺吡啶疗法是只推荐给那些患病时间中等(6 -24个月)，病情重但是没有不良预后特征的患者。
Methotrexate plus hydroxychloroquine is recommended for patients with moderate to high disease activity regardless of disease duration or poor prognostic features.
甲氨喋呤加羟氯喹的疗法是推荐给那些有中高度活动病情的患者，无论这些患者的病程长或短以及有无预后不良因素。
Methotrexate plus hydroxychloroquine is recommended for patients with moderate to high disease activity regardless of disease duration or poor prognostic features.
甲氨喋呤加羟氯喹的疗法是推荐给那些有中高度活动病情的患者，无论这些患者的病程长或短以及有无预后不良因素。
应用推荐